Anke Moret

Anke Moret is Director CMC Regulatory at Ardena, based in Ghent, Belgium. She brings more than two decades of experience in regulatory affairs, with expertise spanning CMC regulatory strategy, operational management, and regulatory project leadership.

Anke first joined Ardena, then known as HEA, in 2001 as Regulatory Affairs Assistant. After leaving the organisation in 2005, she returned in 2009 as Regulatory Affairs Officer and progressed through several key roles, including Senior Regulatory Affairs Officer and Regulatory Project Manager. Since 2021, she has co-led the CMC Regulatory Business Unit together with Julie De Smet, with primary responsibility for operational management and delivery excellence within the unit.

Anke holds a Master’s degree obtained in 2000 and has built extensive expertise in regulatory operations and project management throughout her career in the pharmaceutical industry. In her current role, she works in close partnership with Julie to ensure efficient execution of regulatory projects and to drive continuous improvement across the team.

Ariane De Ganck, PhD

Since 2019, Ariane has overseen Ardena’s drug product activities, spearheading successful integration and transformation at Ardena Pamplona and expanding the company’s capabilities to include sterile services.

With over a decade of senior management experience in CRO/CDMO sectors, Ariane excels in leading multidisciplinary teams and is dedicated to team development, fostering networks, and maintaining a customer-centric approach. Her leadership has also been instrumental in driving business development initiatives.

Prior to joining Ardena, Ariane made significant contributions to the growth of Biogazelle, a specialized CRO in RNA and DNA biomarker services.

Ariane holds a PhD in biomedical sciences, focusing on proteins and oncology